sarcoma Antibody
sarcoma Antibody
![]() |
|||
20-abx211566 | Abbexa |
|
|
|
![]() |
|||
20-abx112510 | Abbexa |
|
|
|
![]() |
|||
20-abx129036 | Abbexa |
|
|
|
![]() |
|||
20-abx129797 | Abbexa |
|
|
|
![]() |
|||
abx145934-100ug | Abbexa | 100 ug | EUR 391 |
|
![]() |
|||
abx012141-100ul | Abbexa | 100 ul | EUR 411 |
|
![]() |
|||
20-abx013365 | Abbexa |
|
|
|
![]() |
|||
20-abx320346 | Abbexa |
|
|
|
![]() |
|||
abx331773-100ul | Abbexa | 100 ul | EUR 425 |
|
![]() |
|||
20-abx325863 | Abbexa |
|
|
|
![]() |
|||
20-abx002015 | Abbexa |
|
|
|
![]() |
|||
C0035002 | Addexbio | One Frozen vial | EUR 669 |
![]() |
|||
abx028153-400ul | Abbexa | 400 ul | EUR 523 |
|
![]() |
|||
abx028153-80l | Abbexa | 80 µl | EUR 286 |
|
![]() |
|||
20-abx014838 | Abbexa |
|
|
|
![]() |
|||
20-abx112395 | Abbexa |
|
|
|
![]() |
|||
20-abx115964 | Abbexa |
|
|
|
![]() |
|||
20-abx115965 | Abbexa |
|
|
|
![]() |
|||
abx145219-100ug | Abbexa | 100 ug | EUR 391 |
|
![]() |
|||
abx034123-400ul | Abbexa | 400 ul | EUR 523 |
|
![]() |
|||
abx034123-80l | Abbexa | 80 µl | EUR 286 |
|
![]() |
|||
BNCR2085-250 | Biotium | 250uL | EUR 394 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), RPE conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNCR2946-250 | Biotium | 250uL | EUR 394 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), RPE conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNUB2051-100 | Biotium | 100uL | EUR 264 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), Concentration: 0.2mg/mL |
![]() |
|||
BNUB2051-50 | Biotium | 50uL | EUR 405 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), 1mg/mL |
![]() |
|||
BNUB2051-500 | Biotium | 500uL | EUR 513 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), Concentration: 0.2mg/mL |
![]() |
|||
BNUB2062-100 | Biotium | 100uL | EUR 264 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), Concentration: 0.2mg/mL |
![]() |
|||
BNUB2062-50 | Biotium | 50uL | EUR 405 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), 1mg/mL |
![]() |
|||
BNUB2062-500 | Biotium | 500uL | EUR 513 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), Concentration: 0.2mg/mL |
![]() |
|||
BNUB2085-100 | Biotium | 100uL | EUR 264 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), Concentration: 0.2mg/mL |
![]() |
|||
BNUB2085-50 | Biotium | 50uL | EUR 405 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), 1mg/mL |
![]() |
|||
BNUB2085-500 | Biotium | 500uL | EUR 513 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), Concentration: 0.2mg/mL |
![]() |
|||
BNUB2946-100 | Biotium | 100uL | EUR 264 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), Concentration: 0.2mg/mL |
![]() |
|||
BNUB2946-50 | Biotium | 50uL | EUR 405 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), 1mg/mL |
![]() |
|||
BNUB2946-500 | Biotium | 500uL | EUR 513 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), Concentration: 0.2mg/mL |
![]() |
|||
BNC552051-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF555 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC552051-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF555 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC552062-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF555 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC552062-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF555 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC552085-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF555 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC552085-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF555 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC552946-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF555 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC552946-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF555 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC612051-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF660R conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC612051-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF660R conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC612062-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF660R conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC612062-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF660R conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC612085-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF660R conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC612085-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF660R conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC432062-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF543 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC432062-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF543 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC432085-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF543 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC432085-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF543 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC432946-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF543 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC432946-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF543 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC472051-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF647 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC472051-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF647 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC472062-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF647 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC472062-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF647 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC472085-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF647 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC472085-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF647 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC472946-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF647 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC472946-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF647 conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC042051-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF405S conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC042051-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF405S conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC042062-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF405S conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC042062-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF405S conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC042085-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF405S conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC042085-500 | Biotium | 500uL | EUR 545 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF405S conjugate, Concentration: 0.1mg/mL |
![]() |
|||
BNC042946-100 | Biotium | 100uL | EUR 233 |
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF405S conjugate, Concentration: 0.1mg/mL |